Strategic Investment Solutions’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
275
﹤0.01% 734
2026
Q1
$0 Hold
275
﹤0.01% 711
2025
Q4
$0 Hold
275
﹤0.01% 676
2025
Q3
$0 Hold
275
﹤0.01% 652
2025
Q2
$0 Hold
275
﹤0.01% 693
2025
Q1
$0 Hold
275
﹤0.01% 698
2024
Q4
$0 Hold
275
﹤0.01% 709
2024
Q3
$0 Sell
275
-5,225
-95% ﹤0.01% 709
2024
Q2
$6.43K Buy
+5,500
New +$6.43K ﹤0.01% 401
2023
Q4
$0 Sell
275
-17,050
-98% ﹤0.01% 1203
2023
Q3
$2.28K Buy
17,325
+17,050
+6,200% +$8.01K ﹤0.01% 693
2023
Q2
$194 Hold
275
﹤0.01% 832
2023
Q1
$382 Buy
+275
New +$519 ﹤0.01% 964

Strategic Investment Solutions's NMTR Position: Q2 2026 in Review

Strategic Investment Solutions held its 9 Meters Biopharma (NMTR) position steady in Q2 2026 at 275 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Strategic Investment Solutions first reported a position in NMTR in Q1 2023 and has held it in 13 quarters since. The position peaked at $6.43K in Q2 2024. 1 fund tracked by Wall St. Rank holds NMTR as of Q2 2026.

  • Strategic Investment Solutions held 275 shares of 9 Meters Biopharma worth $0 as of Q2 2026.
  • Strategic Investment Solutions left its 9 Meters Biopharma share count unchanged in Q2 2026.
  • 9 Meters Biopharma made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #734 holding.
  • Strategic Investment Solutions first reported a position in 9 Meters Biopharma in Q1 2023 and has held it in 13 quarters since.
  • Strategic Investment Solutions's 9 Meters Biopharma position peaked at $6.43K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.